AbelZeta Pharma is a global clinical-stage biopharmaceutical company focused on leveraging our R&D capabilities to discover and develop T cell-based therapeutic products to treat cancer and inflammatory & immunological diseases.
Hematological Cancers
Solid Tumors
Inflammatory & Immunological Diseases
Our PlatformS
CAR-T
Chimeric Antigen Receptor (CAR)-T Cell
TIL
Tumor Infiltrating Lymphocytes (TIL)